Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus

Am J Obstet Gynecol. 2009 Feb;200(2):e6-9. doi: 10.1016/j.ajog.2008.08.056. Epub 2008 Dec 25.

Abstract

Primitive neuroectodermal tumor of the uterine corpus (PNET) is rare and appears to have an aggressive clinical course. We report on a postmenopausal woman with optimal surgically cytoreduced advanced-stage PNET in which adjuvant combination chemotherapy with platinum and taxane agents was unsuccessful in extending her disease-free survival.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Carboplatin / administration & dosage
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Humans
  • Middle Aged
  • Neuroectodermal Tumors, Primitive / complications
  • Neuroectodermal Tumors, Primitive / drug therapy*
  • Neuroectodermal Tumors, Primitive / therapy
  • Paclitaxel / administration & dosage
  • Postmenopause
  • Radiotherapy, Adjuvant
  • Uterine Hemorrhage / etiology
  • Uterine Neoplasms / complications
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / therapy

Substances

  • Carboplatin
  • Paclitaxel